These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8650489)

  • 1. Ethiologic treatment of acute and chronic Chagas' Disease [corrected].
    Fragata Filho AA; da Silva MA; Boainain E
    Sao Paulo Med J; 1995; 113(2):867-72. PubMed ID: 8650489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benznidazole for Chronic Chagas' Cardiomyopathy.
    Urbina JA; Gascon J; Ribeiro I
    N Engl J Med; 2016 Jan; 374(2):189. PubMed ID: 26760095
    [No Abstract]   [Full Text] [Related]  

  • 3. Benznidazole for Chronic Chagas' Cardiomyopathy.
    Cordeiro MA
    N Engl J Med; 2016 Jan; 374(2):188-9. PubMed ID: 26760094
    [No Abstract]   [Full Text] [Related]  

  • 4. Benznidazole for Chronic Chagas' Cardiomyopathy.
    Hamers RL; van Gool T; Goorhuis A
    N Engl J Med; 2016 Jan; 374(2):188. PubMed ID: 26760093
    [No Abstract]   [Full Text] [Related]  

  • 5. Benznidazole for Chronic Chagas' Cardiomyopathy.
    Morillo CA; Marin-Neto JA; Avezum A
    N Engl J Med; 2016 Jan; 374(2):189-90. PubMed ID: 26760092
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of chronic Chagas' disease. Is the etiological treatment effective?].
    Rassi A; Rassi Júnior A
    Arq Bras Cardiol; 1998 Oct; 71(4):643-6. PubMed ID: 10347944
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.
    Morillo CA; Marin-Neto JA; Avezum A; Sosa-Estani S; Rassi A; Rosas F; Villena E; Quiroz R; Bonilla R; Britto C; Guhl F; Velazquez E; Bonilla L; Meeks B; Rao-Melacini P; Pogue J; Mattos A; Lazdins J; Rassi A; Connolly SJ; Yusuf S;
    N Engl J Med; 2015 Oct; 373(14):1295-306. PubMed ID: 26323937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are imidazolic drugs effective in the treatment of chronic Chagas cardiomyopathy?
    Vallejo M; Reyes PA
    Salud Publica Mex; 2003; 45(4):243-4. PubMed ID: 12974040
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Chagas' Disease--Time Is Running Out.
    Maguire JH
    N Engl J Med; 2015 Oct; 373(14):1369-70. PubMed ID: 26323936
    [No Abstract]   [Full Text] [Related]  

  • 10. [Allopurinol in the treatment of chronic Chagas' disease].
    Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
    Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial.
    Rassi A; Marin JA; Rassi A
    Mem Inst Oswaldo Cruz; 2017 Mar; 112(3):224-235. PubMed ID: 28225900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
    Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
    J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Heart Disease after Treatment of Oral Acute Chagas Disease.
    Antunes AF; Maduro SG; Pereira BV; Barbosa Md; Guerra JA; Ferreira JM
    Arq Bras Cardiol; 2016 Aug; 107(2):184-6. PubMed ID: 27627643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs.
    Laguens RP; Cabeza Meckert P; Chambó JG; Gelpi R
    Medicina (B Aires); 1983; 43(2):126-30. PubMed ID: 6420640
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe myocarditis and esophagitis during reversible long standing Chagas' disease recrudescence in immunocompromised host.
    Simões MV; Soares FA; Marin-Neto JA
    Int J Cardiol; 1995 May; 49(3):271-3. PubMed ID: 7649674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).
    Marin-Neto JA; Rassi A; Morillo CA; Avezum A; Connolly SJ; Sosa-Estani S; Rosas F; Yusuf S;
    Am Heart J; 2008 Jul; 156(1):37-43. PubMed ID: 18585495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should benznidazole be used in chronic Chagas' disease?
    Bestetti RB
    Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanisms responsible for myocardial damage progression in chronic Chagas' disease].
    Dávila-Spinetti DF; Colmenarez-Mendoza HJ; Lobo-Vielma L
    Rev Esp Cardiol; 2005 Sep; 58(9):1007-9. PubMed ID: 16185611
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute Chagas' disease: transmission routes, clinical aspects and response to specific therapy in diagnosed cases in an urban center].
    Shikanai-Yasuda MA; Lopes MH; Tolezano JE; Umezawa E; Amato Neto V; Barreto AC; Higaki Y; Moreira AA; Funayama G; Barone AA
    Rev Inst Med Trop Sao Paulo; 1990; 32(1):16-27. PubMed ID: 2124370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.